AMGN vs MRNA
By Alex · Tickerpine
Amgen Inc. vs Moderna, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | MRNA |
|---|---|---|
| Price | $416.18 | $63.67 |
| Market cap | $225.15B | $25.42B |
| P/E ratio | 25.7 | — |
| ROE | 91.47% | -39.00% |
| Profit margin | 22.95% | -141.43% |
| Revenue growth | 9.50% | 2.10% |
| Dividend yield | 2.43% | — |
| Beta | 0.41 | 0.90 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs MRNA in plain English
- AMGN is the bigger company — about 8.9× the market cap of MRNA.
- AMGN earns a higher return on equity (91% vs -39%).
- AMGN is growing revenue faster (10% vs 2%).
- AMGN pays a dividend (2.43%) while the other effectively doesn't.
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
MRNA return calculator
See what $1,000 in Moderna, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.